The Triad of Endothelial Dysfunction, Cardiovascular Disease, and Erectile Dysfunction: Clinical Implications

European Urology, Supplements

Volumn 8, Issue 2, 2009, Pages 58-66

  Montorsi, Piero ^a   Ravagnani, Paolo M ^a   Galli, Stefano ^a   Ali, Sarah Ghulam ^a   Briganti, Alberto ^b   Salonia, Andrea ^b   Montorsi, Francesco ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Erectile dysfunction

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; N(G),N(G) DIMETHYLARGININE; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOPPLER FLOWMETRY; ELECTRON BEAM TOMOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ERECTILE DYSFUNCTION; HUMAN; MEDLINE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

EID: 57049110369     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2008.10.010     Document Type: Review

References (53)

1. Feldman H.A., Goldstein I., Hatzichristou D., Krane R.J., and McKinlay J.B. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 151 (1994) 54-61
2. Bortolotti A., Parazzini F., Colli E., and Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 20 (1997) 323-334
3. Solomon H., Man J.W., Wierzbicki A.S., and Jackson G. Relation of erectile dysfunction to angiographic artery disease. Am J Cardiol 91 (2002) 230-231
4. Montorsi F., Briganti A., Salonia A., et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44 (2003) 360-365
5. Kloner R., Mullin S., Shook T., et al. Erectile dysfunction in the cardiac patient: how common and should we treat?. J Urol 170 (2003) S46-50
6. Gazzarusso C., Giordanetti S., De Amici E., et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110 (2004) 22-26
7. Korpelainenl J.T., Kauhanen M.L., Kemola H., Malinen U., and Myllyla V.V. Sexual dysfunction in stroke patients. Acta Neurol Scand 98 (1998) 400-405
8. Burchard M., Burchard T., Anastasiadis A.G., Kiss A.J., Shabsigh A., and de La Taille A. Erectile dysfunction is a marker for CV complications and psychological functioning in men with hypertension. Int J Impot Res 13 (2001) 276-281
9. Virag R., and Bouilly P. Is impotence an arterial disease? A study of arterial risk factors in 440 impotence men. Lancet 322 (1985) 181-184
10. Azadzoi K.M., and Goldstein I. Erectile dysfunction due to atherosclerotic vascular disease: the development of a animal model. J Urol 147 (1992) 1675-1681
11. Azadzoi K.M., and deTeiada I.S. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 146 (1991) 238-240
12. Solomon H., Man J.W., and Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89 (2003) 179-184
13. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
14. Welt F.G.P., and Simon D.I. Atherosclerosis and plaque rupture. Catheter Cardiovasc Interv 53 (2001) 56-63
15. Crisby M., Nordin-Fredrikson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
16. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81 (1990) 491-497
17. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., and Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. JACC 24 (1994) 1468-1474
18. Halcox J.P.J., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-665
19. Neunteufl T., Hgeher S., Katzenschlager R., et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 86 (2000) 207-210
20. Sonetti P.O., Lerman L.O., and Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23 (2003) 168-175
21. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 94 (1996) 258-265
22. West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1307
23. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
24. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315 (1986) 1046-1051
25. Celermajer D.S., Soresen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
26. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. JACC 39 (2002) 257-265
27. Celermajer D.S., Adams M.R., Clarkson P., et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334 (1996) 150-154
28. Anderson T., Uehata A., Gerhard M., et al. Close relation of endothelial function in the human coronary and peripheral circulations. JACC 26 (1995) 1235-1241
29. Jarvisalo M.J., Juonala J., and Raitakari O.T. Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care 9 (2006) 547-552
30. Ferri C., Carlomagno E., Coassin S., et al. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamping lean NIDDM men. Diabetes Care 18 (1995) 226-233
31. Ferri C., Desideri G., Valenti M., et al. Early up-regulation of endothelial adhesion molecules in obese hypertensives men. Hypertension 34 (1999) 568-573
32. Fasching P., Waldhausl W., and Wagner O.F. Elevated circulating adhesion molecules in NIDDM: potential mediators in diabetic macroangiopathy. Diabetologia 39 (1996) 1242-1244
33. Cooke J.P. Asymmetrical dimethylarginine. The Uber marker?. Circulation 109 (2004) 1813-1819
34. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
35. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. JACC 46 (2005) 1693-1701
36. Bassuk S.S., Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: clinical implication. Curr Prob Cardiol 29 (2004) 439-493
37. Bocchio M., Desideri G., Scarpelli P., et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 171 (2004) 1601-1604
38. Kaiser D.R., Billups K., Mason C., Wetterling R., Lundberg J.L., and Blank J. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. JACC 43 (2004) 179-184
39. Elesber A.A., Solomon H., Lennon R.J., et al. Coronary endothelium dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 27 (2006) 824-831
40. Vlachopoulos C., Rokkas K., Ioakeimidis N., and Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction and coronary artery disease: common links. Eur Urol 52 (2007) 1590-1600
41. Vlachopoulos C., Aznaouridis K., Ioakeimidis N., et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 27 (2006) 2640-2648
42. Jackson G. Erectile dysfunction, like diabetes, should be considered a 'cardiovascular equivalent'. Int J Clin Prac 59 (2005) 507
43. Montorsi P., Ravagnani P.M., Galli S., et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol 50 (2006) 721-731
44. Kostis J.B., Jackson G., Rosen R., et al. Sexual dysfunction and cardiac risk. The Second Princeton Consensus Conference. Am J Cardiology 96 (2005) 313-321
45. Esposito K., Giugliano F., Di Palo C., et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291 (2004) 2978-2984
46. Sullivan M.E., Thompson C.S., Dashwood M.R., et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?. Cardiovasc Res 43 (1999) 658-665
47. Saltzman E.A., Guay A.T., and Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 172 (2004) 255-258
48. Castro M.M., Rizzi E., Rascado R.R., et al. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol 498 (2004) 189-194
49. Blumentals W.A., Gomez-Caminero A., and Vannappagari S.J. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 16 (2004) 350-353
50. Thompson I.M., Tangen C.M., Goodman P.J., et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 294 (2005) 2996-3002
51. Gazzaruso C., Solerte S., Pujia A., et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease. JACC 51 (2008) 2040-2044
52. Ma R.C., So W.Y., Yang X., et al. Erectile dysfunction predicts coronary artery disease in type 2 diabetes. JACC 51 (2008) 2045-2050
53. Schounten B.W., Bohnen A.M., Bosch J.L., et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: result from the Krimpen study. Int J Impot Res 20 (2008) 92-99